Boston Scientific Corp <BSX.N>: Truist Securities cuts target price to $57 from $62
BSX•Related News
SCI Engineered Materials Q2 FY26 net income rises 221% to $1.17 million; revenue more than doubled to $9.49 million
SCIA•
electroCore to report Q2 financial results, host investor webinar
ECOR•
Stride Announces CEO Succession
LRN•
Shell Ann Godbehere Will Step Down As Chair And A Member Of Arc With Effect From August 1, 2026
SHEL•
Mira Pharmaceuticals advances MIRA-55 toward IND-enabling studies after completing exploratory tox dosing in rats, dogs
MIRA•